SPOTLIGHT -
February 14th 2023
Prevalence of IBD doubled between 1995 and 2016 and exposure to antibiotics may be to blame.
January 20th 2023
There are no currently approved medications for the treatment of NASH.
December 19th 2022
Successful clinical trials for digestive health treatments may soon yield approvals.
November 17th 2022
New research indicates that gay men are at increased risk of inflammatory bowel disease.
November 16th 2022
New research illustrates the efficacy of upadacitinib for treating Crohn's and ulcerative colitis.
Stelara Study Shows Efficacy for Ulcerative Colitis
Clinical trial results reported at United European Gastroenterology Week 2022 highlight Stelara's effectiveness.
Robotic Capsule Can Help Patients Digest Vancomycin, Insulin
Technlogy could greatly improve drug absorption.
First Immunotherapy Combo Treatment Approved for Biliary Tract Cancers
FDA approves durvalumab to treat biliary tract cancer in combination with chemotherapy.
Babies Given Antibiotics May Have Adult GI Issues
New research adds further evidence that early in life antibiotic exposure can have lifelong impact.
FDA Approves Voquezna for Helicobacter pylori Infection in Adults
This new treatment option copackages 3 drugs for optimal treatment.
Certain Skin Diseases More Likely in Patients with Inflammatory Bowel Disease
New research examines how often immune-mediated inflammatory skin diseases occur in patients with inflammatory bowel disease.
Inflammatory Bowel Disease Treatment Costs Reduced with IFX biosimilar
Although further studies are needed to confirm the long-term effects, recent studies have shown the infliximab biosimilar to be a safe, effective, and cost reducing treatment for inflammatory bowel diseases.
Guidelines Strongly Recommend Linzess for IBS-C
The American Gastroenterological Association has released updated guidelines for treating irritable bowel syndrome with constipation (IBS-C).
Top 3 Crohn’s Disease, Ulcerative Colitis Treatments Are on the Way
Treatments, including some biosimilars, may soon be offering relief to patients.
Daily Harvest Issues Widespread Recall as Reports of Gastrointestinal Emergencies Surface
Pharmacists who encounter patients with severe gastrointestinal complains may want to stay abreast of ongoing issues with the meal delivery service.
Immunology Pipeline Includes New Approvals, Expanded Indications for Dermatology, Reparatory, and GI
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
Treating Cannabinoid Hyperemesis Syndrome in the Emergency Department
High-dose haloperidol and aprepitant were both associated with emergency department discharge.
Antibiotics Linked to Higher IBD Risk in Older Adults
Seniors prescribed multiple courses of antibiotics were at greater risk for IBD.
Pharmacy-Driven Probiotic Protocol Reduces Rates of C Diff Infection in an Inpatient Setting
Patients taking high-risk antibiotics and a probiotic capsule had a lower risk of healthcare-associated C diff infections.
C Diff Infections More Common With Digestive Tract Surgeries
Reducing perioperative antibiotic use can mitigate this risk.
COVID-19 Vaccine Safe, Effective for People With IBD
Concerns were raised about the effectiveness of the vaccine in patients on immunosuppressive therapies.
Meaningful Health Care Visits Needed for IBS, Chronic Idiopathic Constipation
Patients report that these conditions have become more challenging to manage over the past year.
Tapentadol Vs Oxycodone Evaluated for Postoperative Gastrointestinal Adverse Drug Events
Postoperative pain can require opioids, which may lead to opioid-induced constipation.
Relationship Between Non-Celiac Gluten Sensitivity, IBS Identified
Patients experiencing IBS were more likely to self-report a non-celiac gluten sensitivity.
Cannabinoid Hyperemesis Syndrome: Diagnosis and Management
A deep dive for pharmacists into this frequently debilitating disorder
Survey Results Reveal Potential IBS-Migraine Link
Migraine is highly prevalent in people living with IBS.
Combination Treatment Shows Promise for Ulcerative Colitis
Tremfaya is a combination of guselkumab and golimumab.
Resmetirom Safe, Well-Tolerated in Non-Alcoholic Fatty Liver Disease
Resmetirom also has potential as a treatment for NASH.
Increased Abdominal Pain Risk Associated With Antibiotic Use During First Week of Life
Treating Gut Disorders With Open-Label Placebo
A clinical trial looks into whether the use of open-label placebos can lead to better outcomes for children and teenagers with functional abdominal pain or irritable bowel syndrome.
Half of Pediatric Opioid Prescriptions are High Risk
Many pediatric opioid prescriptions are high risk and leave children at risk of overdose and side effects like constipation.
Exploring the Efficacy, Safety of Rotavirus Vaccines
A meta-analysis in JAMA Pediatrics looks at whether vaccines can prevent rotavirus gastroenteritis.
Study Links Processed Food to Inflammatory Bowel Disease
A study published in The BMJ revealed a link between ultra-processed foods and a higher risk of IBD.
Addressing Constipation in Pregnant, Postpartum Women
The results of a new study show that constipation prevalence was 2- to 3-fold higher in pregnant women and women postpartum.
Constipation: Causes and Tips for Prevention
What pharmacists should know about constipation.